Lamotrigine use in pregnancy

Journal of Pharmacy Technology

Volumn 15, Issue 3, 1999, Pages 75-78

  Lilly, Carol L ^a   Kaplan Machlis, Barbara ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CYTOCHROME P450; FOLIC ACID ANTAGONIST; LAMOTRIGINE; OXIDE; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL TRIAL; DRUG METABOLISM; DRUG SAFETY; EPILEPSY; FETUS MALFORMATION; FOLIC ACID DEFICIENCY; GROWTH RETARDATION; HUMAN; NEURAL TUBE DEFECT; PREGNANCY; PREGNANCY COMPLICATION; PROTEIN BINDING; REFERENCE VALUE; TERATOGENESIS; TREATMENT OUTCOME;

EID: 0032812944     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512259901500302     Document Type: Article

References (26)

1. Morrell MJ. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome. Epilepsia 1996;37 (suppl 6):S34-44.
2. Minkoff H, Schaffer RM, Delke I, Grunebaum AN. Diagnosis of intracranial hemorrhage in utero after a maternal seizure. Obstet Gynecol 1985;65(suppl 3):22S-4S.
3. Lewis DP, Van Dyke DC, Stumbo PJ, Berg MJ. Drug and environmental factors associated with adverse pregnancy outcomes. Part I: antiepileptic drugs, contraceptives, smoking, and folate. Ann Pharmacother 1998;32:802-17.
4. Lacy D, Armstrong LL, Ingrim NB, Lance LL, eds. Drug information handbook. 5th ed. Hudson, OH: Lexi-Comp, 1997.
5. Koren G, Pastszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338:1128-37.
6. Kaneko S, Otani K, Fukushima Y. Teratogenicity of antiepilepsy drugs - analysis of possible risk factors. Epilepsia 1988;29:459-67.
7. Schon M. Treating recurrent affective disorders during and after pregnancy. Drug Saf 1998;18:143-52.
8. Lindhout D, Omizigt JG, Cornel MC. Spectrum of neural tube defects in 34 infants prenatally exposed to antiepileptic drugs. Neurology 1992;42(suppl 5):111-8.
9. Ogawa Y, Kaneko S, Otani K, Fukushima Y. Serum folic acid levels in epileptic mothers and their relationship to congenital malformations. Epilepsy Res 1991;8:75-8.
10. Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F. Anticonvulsants, folate levels, and pregnancy outcome: a prospective study. Ann Neurol 1987;21:176-82.
11. Mulinare J, Corder JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-5.
12. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, et al. Muitivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989; 262:2847-52.
13. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993; 269:1257-61.
14. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
15. Medical Research Council Vitamin Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-7.
16. Van Allen MI, Fraser FC, Dallaire L, Allanson J, McLeod DR, Andermann E, et al. Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Can Med Assoc J 1993;149:1239-43.
17. Centers for Disease Control and Prevention. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41:1-7.
18. Yerby MS, Friel PN, McCormick K. Antiepileptic drug disposition during pregnancy. Neurology 1992;42(suppl 5):12-6.
19. Package insert. Lamictal (lamotrigine). Research Triangle Park, NC: Glaxo Wellcome, April 1997.
20. Gilman JT Lamotrigine: an antiepileptic agent for the treatment of partial seizures. Ann Pharmacother 1995;29:144-51.
21. Sander JWAS, Patsalos PN. An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy. Epilepsy Res 1992;13:89-92.
22. Rambeck B, Kurlemann G, Stodieck SG, May TW, Jurgens U. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur J Clin Pharmacol 1997;51:481-4.
23. Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 1993;25:433-43.
24. Quattrini A, Ortenzi A, Paggi A, Foschi N, Quattrini C. Lamotrigine and pregnancy (letter). Ital J Neurol Sci 1996;17:441.
25. Tomson T, Ohman I, Vitols S. Lamotrigine in pregnancy and lactation: a case report. Epilepsia 1997;38:1039-41.
26. A North American registry for epilepsy and pregnancy, a unique public/private partnership of health surveillance. Epilepsia 1998, 39.793-8.